SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-063561
Filing Date
2024-05-20
Accepted
2024-05-20 20:04:05
Documents
1
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2414961-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2414961-4_4seq1.xml 4 4182
  Complete submission text file 0001104659-24-063561.txt   5622
Mailing Address C/O BIOVEX GROUP, INC. 34 COMMERCE WAY WOBURN MA 10801
Business Address
Astley-Sparke Philip (Reporting) CIK: 0001376491 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 24966564

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Issuer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)